Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Wesolowski

Showing results (91-100 of 136) with videos related to

Pageof 14
Sort By:
Breast Cancer Research : BCR|July 2, 2025
Palazestrant, a novel oral Complete Estrogen Receptor Antagonist (CERAN) and Selective Estrogen Receptor Degrader (SERD), in patients with ER+/HER2- advanced or metastatic breast cancer: phase 1/2 study resultsErika P Hamilton, Manish R Patel, Virginia F Borges, et al.
World Journal of Surgical Oncology|January 16, 2020
Assessment of outcomes and novel immune biomarkers in metaplastic breast cancer: a single institution retrospective studyEvan Morgan, Anupama Suresh, Akaansha Ganju, et al.
Investigational New Drugs|January 19, 2020
A phase I study of an oral selective gamma secretase (GS) inhibitor RO4929097 in combination with neoadjuvant paclitaxel and carboplatin in triple negative breast cancerSagar Sardesai, Mohamed Badawi, Ewa Mrozek, et al.
NPJ Breast Cancer|November 15, 2024
Baseline gut microbiome alpha diversity predicts chemotherapy-induced gastrointestinal symptoms in patients with breast cancerLauren D Otto-Dobos, Lindsay D Strehle, Brett R Loman, et al.
Frontiers in Endocrinology|May 16, 2020
TTF-1 Positive Primary Small Cell Carcinoma of the Breast: A Case Report and Review of the LiteratureHinda Boutrid, Mahmoud Kassem, Gary Tozbikian, et al.
Breast Cancer Research : BCR|March 8, 2014
Heterogeneous atypical cell populations are present in blood of metastatic breast cancer patientsMaryam B Lustberg, Priya Balasubramanian, Brandon Miller, et al.
Cancer Medicine|April 9, 2022
A phase I study of talazoparib (BMN 673) combined with carboplatin and paclitaxel in patients with advanced solid tumors (NCI9782)Ticiana A Leal, Marina N Sharifi, Nancy Chan, et al.
Journal of Clinical Medicine|February 15, 2022
Long-Term Follow-Up of Fractional CO<sub>2</sub> Laser Therapy for Genitourinary Syndrome of Menopause in Breast Cancer SurvivorsAllison M Quick, Andrew Hundley, Cynthia Evans, et al.
European Journal of Breast Health|July 14, 2020
Features, Outcomes, and Management Strategies of Male Breast Cancer: A Single Institution Comparison to Well-Matched Female ControlsJoseph Liu, Anupama Suresh, Marilly Palettas, et al.
Psychoneuroendocrinology|March 22, 2025
The role of oxytocin in mediating the relationships between social factors and chemotherapy-associated cognitive decline in female patients with breast cancerMelina M Seng, Seth Adarkwah Yiadom, Lauren D Otto-Dobos, et al.
Pageof 14

Showing results (91-100 of 136) with videos related to

Sort By:
Pageof 14
Breast Cancer Research : BCR|July 2, 2025
Palazestrant, a novel oral Complete Estrogen Receptor Antagonist (CERAN) and Selective Estrogen Receptor Degrader (SERD), in patients with ER+/HER2- advanced or metastatic breast cancer: phase 1/2 study resultsErika P Hamilton, Manish R Patel, Virginia F Borges, et al.
World Journal of Surgical Oncology|January 16, 2020
Assessment of outcomes and novel immune biomarkers in metaplastic breast cancer: a single institution retrospective studyEvan Morgan, Anupama Suresh, Akaansha Ganju, et al.
Investigational New Drugs|January 19, 2020
A phase I study of an oral selective gamma secretase (GS) inhibitor RO4929097 in combination with neoadjuvant paclitaxel and carboplatin in triple negative breast cancerSagar Sardesai, Mohamed Badawi, Ewa Mrozek, et al.
NPJ Breast Cancer|November 15, 2024
Baseline gut microbiome alpha diversity predicts chemotherapy-induced gastrointestinal symptoms in patients with breast cancerLauren D Otto-Dobos, Lindsay D Strehle, Brett R Loman, et al.
Frontiers in Endocrinology|May 16, 2020
TTF-1 Positive Primary Small Cell Carcinoma of the Breast: A Case Report and Review of the LiteratureHinda Boutrid, Mahmoud Kassem, Gary Tozbikian, et al.
Breast Cancer Research : BCR|March 8, 2014
Heterogeneous atypical cell populations are present in blood of metastatic breast cancer patientsMaryam B Lustberg, Priya Balasubramanian, Brandon Miller, et al.
Cancer Medicine|April 9, 2022
A phase I study of talazoparib (BMN 673) combined with carboplatin and paclitaxel in patients with advanced solid tumors (NCI9782)Ticiana A Leal, Marina N Sharifi, Nancy Chan, et al.
Journal of Clinical Medicine|February 15, 2022
Long-Term Follow-Up of Fractional CO<sub>2</sub> Laser Therapy for Genitourinary Syndrome of Menopause in Breast Cancer SurvivorsAllison M Quick, Andrew Hundley, Cynthia Evans, et al.
European Journal of Breast Health|July 14, 2020
Features, Outcomes, and Management Strategies of Male Breast Cancer: A Single Institution Comparison to Well-Matched Female ControlsJoseph Liu, Anupama Suresh, Marilly Palettas, et al.
Psychoneuroendocrinology|March 22, 2025
The role of oxytocin in mediating the relationships between social factors and chemotherapy-associated cognitive decline in female patients with breast cancerMelina M Seng, Seth Adarkwah Yiadom, Lauren D Otto-Dobos, et al.
Pageof 14